A fungal tRNA of Aspergillus niger induces IFN-β synthesis in HEp-2 cells

Life Sciences

Volumn 77, Issue 5, 2005, Pages 578-588

  Alvarado Vásquez, Noé ^a   Santiago, Julio ^a   Alcázar Leyva, Susana ^b   Zenteno, Edgar ^c   Negrete García, Cristina ^a   Alcázar Montenegro, Heberto ^b  

^a INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

^b Instituto de Investigaciones Científicas Hans Selye A C   (Mexico)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Antiviral agent; Fungal tRNA; HEp 2 cells; IFN beta; Inhibition of cytopathic effect; Interferon inducer; PolyI:polyC; RT PCR

Indexed keywords

ANTIVIRUS AGENT; BETA INTERFERON; FUNGUS TRANSFER RIBONUCLEIC ACID; POLYINOSINIC POLYCYTIDYLIC ACID; RECOMBINANT ALPHA INTERFERON; TRANSFER RNA; UNCLASSIFIED DRUG;

ADENOVIRUS; ARTICLE; ASPERGILLUS NIGER; CELL VIABILITY; CYTOPATHOGENIC EFFECT; HEP 2 CELL; HUMAN; HUMAN CELL; INCUBATION TIME; INTERFERON INDUCTION; INTERFERON PRODUCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS INFECTION;

ADENOCARCINOMA; ADENOVIRIDAE; ANIMALS; ANTIVIRAL AGENTS; ASPERGILLUS NIGER; CELL LINE, TUMOR; CELL SURVIVAL; CERCOPITHECUS AETHIOPS; CYTOPATHOGENIC EFFECT, VIRAL; GENES, FUNGAL; HUMANS; INTERFERON-BETA; LARYNGEAL NEOPLASMS; MITOSIS; POLY I-C; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, TRANSFER; RNA, VIRAL; VERO CELLS; VIRUS REPLICATION;

ADENOVIRIDAE; ASPERGILLUS NIGER; HUMAN ADENOVIRUS TYPE 6;

EID: 19344368941     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2004.11.034     Document Type: Article

References (29)

1. S. Baron, K.S. Tyring, W.R. Fleischmann, D.H. Coppenhaver, D.W. Niesel, G.R. Klimpel, G.J. Stanton, and T.K. Hughes The interferons: mechanisms of action and clinical applications The Journal of the American Medical Association 266 1991 1375 1383
2. G. Carballal, C. Videla, A. Misirlian, P.V. Requeijo, and C. Aguilar Mdel Adenovirus type 7 associated with severe and fatal acute lower respiratory infections in Argentine children BMC Pediatrics 16 2002 6 12
3. S.B. Cheknev, M.V. Mezentseva, A.N. Narovlyansky, N.A. Kobyakina, and F.I. Ershov Correlations between in vitro effects of preparations of interferon and its inducers on blood cells in patients with multiple sclerosis Bulletin of Experimental Biology and Medicine 131 2003 382 384
4. K. Chibana, Y. Ishii, P. Asakura, and T. Fukuda Up-regulation of cysteinil leukotriene 1 receptor by IL-3 enables human lung fibroblasts to respond to leukotriene C4 and produce eotaxin Journal of Immunology 170 2003 4290 4295
5. R.J. Essey, B.R. McDougall, and W.E. Robinson Mismatched double-stranded RNA (polyI-polyC(12)U) is synergistic with multiple anti-HIV drugs and is active against drug-sensitive and drug-resistant HIV-1 in vitro Antiviral Research 51 2001 189 202
6. J. Gabrilovac, M. Ikic-Sutlic, N. Knezevic, and L. Poljak Leu-enkephalin enhances interferon secretion in mice Research in Experimental Medicine (Berl) 196 1996 137 144
7. B.J. Giantonio, H. Hochster, R. Blum, P.H. Wiernik, G.R. Hudes, J. Kirkwood, D. Trump, and M.M. Oken Toxicity and response evaluation of the interferon inducer poly ICLC administered at low dose in advanced renal carcinoma and relapsed or refractory lymphoma: a report of two clinical trials of the Eastern Cooperative Oncology Group Investigation of New Drugs 19 2001 89 92
8. K.B. Hahm, K.Y. Han, W.H. Kim, D.S. Yim, C.Y. Chon, Y.M. Moon, J.K. Kang, and I.S. Park Efficacy of polyadenylic.polyuridylic acid in the treatment of chronic active hepatitis British International Journal of Immunopharmacology 16 1994 217 225
9. 12U) in healthy volunteers Antimicrobial Agents and Chemotherapy 37 1993 429 435
10. X. Huang, J. Yuan, A. Goddard, A. Foulis, R.F.L. James, A. Lernmark, R. Pujol-Borrell, A. Rabinovitch, N. Somoza, and T.A. Stewart Interferon expression in the pancreas of patients with type I diabetes Diabetes 44 1995 658 664
11. Y. Kreiss, Z. Vered, N. Keller, I. Kochva, Y. Sidi, and H. Gur Aspergillus niger endocarditis in an immunocompetent patient: an unusual course Postgraduate Medical Journal 76 2000 105 106
12. J.M. Jamison, J. Gilloteaux, M. Adrian, and J.L. Summers Effect of ethidium on the morphology, antiviral activity and subcellular distribution of poly r(A-U) Cell Biology International 17 1993 1091 1105
13. P. Leyssen, C. Drosten, M. Paning, N. Charlier, J. Paeshuyse, E. De Clercq, and J. Neyts Interferons, interferon inducers, and interferon-ribavirin in treatment of flavivirus-induced encephalitis in mice Antimicrobial Agents and Chemotherapy 47 2003 777 782
14. R. Lopez-Marure, G. Gutierrez, C. Mendoza, J.L. Ventura, L. Sánchez, E. Reyes-Maldonado, A. Zentella, and L.F. Montaño Ceramide promotes the death of human cervical tumor cells in the absence of biochemical and morphological markers of apoptosis Biochemical Biophysical Research Communications 293 2002 1028 1036
15. D. McCracken, R. Barnes, C. Poynton, P.L. White, N. Isik, and D. Cook Polymerase chain reaction aids in the diagnosis of an unusual case of Aspergillus niger endocarditis in a patient with acute myeloid leukemia The Journal of Infection 47 2003 344 347
16. P.G. Milhaud, B. Compagnon, A. Bienvenue, and J.R. Philippot Interferon production of L929 and HeLa cells enhanced by polyriboinosinic acid-polyribocytidylic acid pH-sensitive liposomes Bioconjugate Chemistry 3 1992 402 407
17. J.J. Nordlund, S.M. Wolff, and H.B. Levy Inhibition of biological activity of polyI:polyC by human plasma Proceedings of the Society for Experimental Biology and Medicine 133 1970 439 444
18. C.S. Park, J. Kim, and K.T. Montone Detection of Aspergillus ribosomal RNA using biotinylated oligonucleotide probes Diagnostic Molecular Pathology 6 1997 255 260
19. S.K. Puri, G.P. Dutta, H.B. Levy, and R.K. Maheshwari Poly ICLC inhibits Plasmodium cynomolgi B malaria infection in rhesus monkeys Journal of Interferon and Cytokine Research 16 1996 49 52
20. R. Richman, and R.A. Flickinger Effect of polycations and polyanions on cell division of cultured mammalian cells Life Sciences 35 1984 911 916
21. S. Rubinstein, P.C. Familletti, and S. Pestka Convenient assay for interferons Journal of Virology 37 1981 755 758
22. R.J. Suhadolnik, N.L. Reichenbach, P. Hitzges, M.E. Adelson, D.L. Peterson, P. Cheney, P. Salvato, C. Thompson, M. Loveless, and W.E. Muller Changes in the 2-5A synthetase/RNase L antiviral pathway in a controlled clinical trial with poly(I):poly(C12U) in chronic fatigue syndrome In Vivo 8 1994 599 604
23. K.A. Thompson, D.R. Strayer, P.D. Salvato, C.E. Thompson, N. Klimas, A. Molavi, A.K. Hamill, Z. Zheng, D. Ventura, and W.A. Carter Results of a double-blind placebo-controlled study of the double-stranded RNA drug polyI:polyC12U in the treatment of HIV infection European Journal of Clinical Microbiology and Infectious Diseases 15 1996 580 587
24. S. Ugurlu, A. Maden, N. Sefi, G. Sener, and N. Yulug Aspergillus niger infection of exenterated orbit Ophthalmic Plastic and Reconstructive Surgery 17 2001 452 453
25. P.L. Witt, S. Zahir, P.S. Ritch, T.M. McAuliffe, C.H. Ewel, and E.C. Borden Phase I/IB study of polyadenylic-polyuridylic acid in patients with advanced malignancies: clinical and biological effects Journal of Interferon and Cytokine Research 16 1996 631 635
26. J.P. Wong, E.G. Saravolac, D. Sabuda, H.B. Levy, and M. Kende Prophylactic and therapeutic efficacies of poly(IC:LC) against respiratory influenza A virus infection in mice Antimicrobial Agents and Chemotherapy 39 1995 2574 2576
27. R. Zahorska, M. Korbecki, J. Barciszewski, and U. Wojda Effects of plant transfer ribonucleic acids on interferon production Acta Virologica 29 1985 203 208
28. V.V. Zarubaev, A.V. Slita, V.Z. Krivitskaya, A.K. Sirotkin, A.L. Kovalenko, and N.K. Chatterjee Direct antiviral effect of cycloferon (10-carboxymethyl-9-acridanone) against adenovirus type 6 in vitro Antiviral Research 58 2003 131 137
29. N.M. Zholobak, A.V. Karpov, S.L. Rybalko, S.V. Antonenko, and E.V. Barbasheva Comparative cytotoxic characteristics of the interferon-inducing yeast RNA-tilorone complex Antibiotiki i Khimioterapiia 44 1999 21 24